Innovations are made every day by creative and competent people but very few become commercially successful products.

Sedana Medical was founded 2005 on the premise that the AnaConDa technology is such an innovation.

The availability of the AnaConDa technology makes the administration of anaesthetic agents simple and safe without the need for specialist and expensive equipment.

AnaConDa was developed in Sweden in the mid 90's and tested in a clinical setting for the first time in 1999. Since then over 20 publications have been published and up to middle of 2009 over 15 000 AnaConDa has been used in clinics all over the world providing inhalation sedation. Usage is increasing rapidly.

The use of inhalation sedation, mostly isoflurane but now also sevoflurane, started during the 80's but the difficulty in administration made the treatment regimen impossible to implement in a routine clinical setting. AnaConda has changed all that;

"Initially, the lack of necessary equipment led to limited use of volatile anesthetics as sedative agents in the ICU, but technologic advances, especially the introduction of the AnaConDa filter have greatly simplified administration of volatile anesthetic agents in this setting."
Gommers et al Critical Care 2008, 12(Suppl 3):S4 (doi:10.1186/cc6150).

Sedana Medical is confident that inhalation sedation with the AnaConDa system will become the procedure of choice for long term sedation in the future. Today it is being used and evaluated in patients after cardiac surgery, burns, neuro-surgery, status epilepticus and asthmaticus, COPD, difficult sedations, deep sedation etc.

Sedana Medical is based in Uppsala in Sweden, has a subsidiary in Germany and has a large network of distributors.